LYSSIKATOS JOSEPH P (CHIEF SCIENTIFIC OFFICER) sold 0.7% of their position (5K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $145.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/10/2026ACC: 0001967150-26-000003
Officer· CHIEF SCIENTIFIC OFFICER
Since Feb 2026
-5K
Net shares
Net seller
$145.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−5K
Price / share
$29.04
Trade value
$145.22K
% of position
0.7%
2/6/2026
745.19K→740.19K
Total
Net shares
−5K
Net value
-$145.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/6/2026 | S · Sale | −5K | $29.04 | $145.22K | 0.7% | 745.19K | 740.19K |
| Total | −5K | -$145.22K | ||||||
Derivative Transactions0
No derivative transactions reported